• Technology and Data
  • Front End Sales and Marketing
  • Allergy
  • HIV
  • Women's Health
  • Migraine
  • Compounding
  • Continuous Glucose Monitoring
  • Mental Health Awareness
  • Veterinary Pharmacy
  • CBD
  • Infectious Disease
  • Eye Health
  • Digestive Health
  • Biosimilars
  • Influenza
  • Shingles
  • COPD Management
  • Pediatrics
  • Generics
  • Pain Management
  • COVID-19
  • Immunization
  • Oncology
  • Anticoagulants
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Respiratory
  • Heart Health
  • Cardiovascular Clinical Consult

Coronavirus News Roundup: Extra Doses Found in Pfizer Vaccine, New Studies on MIS-C


Here’s the last roundup of the latest coronavirus-related news in 2020.


FDA Grants EUA to Moderna COVID-19 Vaccine

Last week, the FDA granted emergency use authorization (EUA) to Moderna’s vaccine candidate for COVID-19 for use in individuals 18 years of age and older.

Read more

Pharmacists Can Use Extra Doses Found in Pfizer COVID-19 Vaccine Vials to Expand Supply

Officials with the FDA have affirmed that pharmacists administering the Pfizer/BioNTech COVID-19 vaccine can use leftover doses in vials containing multiple doses, which may boost the US supply by up to 40%, according to reporting by Politico.

Read more

Fauci: US Still Months Away From COVID-19 Vaccine Approval for Children

Although US health care workers have started receiving the Pfizer-BioNTech COVID-19 vaccine, vaccines for children won’t be available for “months,” according to Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases.

Read more

NIH funds 8 new studies on COVID-19 related MIS-C in children

The National Institutes of Health (NIH) has awarded 8 new research grants to help identify children who are at high risk of contracting multisystem inflammatory syndrome in children (MIS-C), a severe result of COVID-19 in some children.

Read more on Contemporary Pediatrics

Related Videos
© 2023 MJH Life Sciences

All rights reserved.